Composite CYP3A phenotypes influence tacrolimus dose-adjusted concentration in lung transplant recipients.

Saved in:
Bibliographic Details
Title: Composite CYP3A phenotypes influence tacrolimus dose-adjusted concentration in lung transplant recipients.
Authors: Liu M; Department of Pharmacy, Vanderbilt University Medical Center., Shaver CM; Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center., Birdwell KA; Division of Nephrology, Department of Medicine, Vanderbilt University Medical Center., Heeney SA; Department of Pharmacy, Vanderbilt University Medical Center., Shaffer CM; Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center., Van Driest SL; Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center.; Division of General Pediatrics, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Source: Pharmacogenetics and genomics [Pharmacogenet Genomics] 2022 Jul 01; Vol. 32 (5), pp. 209-217. Date of Electronic Publication: 2022 Apr 07.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101231005 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-6880 (Electronic) Linking ISSN: 17446872 NLM ISO Abbreviation: Pharmacogenet Genomics Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1744-6880
DOI:10.1097/FPC.0000000000000472